Brief: Emergent Biosolutions Announces The Execution Of Contract Options Valued At $67.4 Million To Procure Additional Tembexa

Emergent BioSolutions

26/09/2024 13:26

Sept 26 (Reuters) - Emergent BioSolutions Inc  EBS.N :
    * EMERGENT BIOSOLUTIONS ANNOUNCES THE EXECUTION OF CONTRACT
OPTIONS VALUED AT $67.4 MILLION TO PROCURE ADDITIONAL TEMBEXA®
(BRINCIDOFOVIR) TO SUPPORT NATIONAL PREPAREDNESS EFFORTS
    * EMERGENT BIOSOLUTIONS INC - CONTRACT HAS MAXIMUM POTENTIAL
VALUE
OF $568 MILLION
    * EMERGENT BIOSOLUTIONS INC - FUNDING COMMITTED THROUGH 2027
FOR
TEMBEXA SUPPLY

Source text for Eikon:  ID:nGNXb17Bcx 
Further company coverage:  EBS.N 

 ((Reuters.Briefs@thomsonreuters.com;))